1.3-benzoxazol derivatives are replaced by bicyclic nitroisocyclic compounds and PI3-500 inhibitors, and are used for PI3 500 enzyme disorders related to asthma, aerosol, bronchitis, rheumatoid arthritis, pancreatitis, diabetes, cancer, etc.
REN PINGDA,LIU YI,LI LIANSHENG,CHAN KATRINA,WILSON TROY EDWARD,CAMPBELL SIMON FRASER.
申请号：
CL2012000427
公开号：
CL2012000427A1
申请日:
2012.02.17
申请国别(地区):
CL
年份:
2012
代理人:
摘要：
e. G. lt； P gt； compounds made of non nitro compounds, 13-500 inhibitors, an M amp, eacute； all substances used to inhibit P13 quinase activity in vitro； and a disorder related to lap13 500 enzyme, including asthma, aerosols, bronchitis, rheumatoid arthritis, pancreatitis, diabetes, etc.<；p>；Compuestos derivados de heterociclos nitrogenados, inhibidores de P13 quinasas； un mé；todo in vitro para inhibir la actividad de P13 quinasa； y su uso en un trastorno asociado a LAP13 quinasa seleccionado de asma, efisema, bronquitis, artritis reumatoidea, pancreastitis, diabetes, entre otras.<；/p>；
